virology
Showing 26 - 50 of 583
Genital Herpes Trial in Seattle (acyclovir, valacyclovir)
Completed
- Genital Herpes
-
Seattle, WashingtonUniversity of Washington Virology Research Clinic
Nov 16, 2021
HIV Infection Trial in Baltimore (300 ug FLSC vaccine, 150 ug FLSC vaccine, 75 ug FLSC vaccine)
Completed
- HIV Infection
- 300 ug FLSC vaccine
- +3 more
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Nov 15, 2021
HIV+ Deceased Donor Transplant for HIV+ Recipients
Recruiting
- HIV Infection
- HIV-infected deceased donor organ
-
Aurora, Colorado
- +17 more
May 4, 2022
Monkeypox Trial in United States (JYNNEOS)
Not yet recruiting
- Monkeypox
- JYNNEOS
-
San Diego, California
- +7 more
Aug 20, 2022
Congenital Cytomegalovirus Infection Trial in United States (Valganciclovir)
Active, not recruiting
- Congenital Cytomegalovirus Infection
-
Birmingham, Alabama
- +8 more
Aug 18, 2022
Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],
Completed
- Hepatitis B
- Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
- +2 more
-
Baltimore, MarylandInstitute of Human Virology (IHV), University of Maryland Baltim
Aug 24, 2021
HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)
Completed
- HIV/AIDS
- PGT121 + VRC07-523LS
- PGT121 + VRC07-523LS + PGDM1400
-
Orlando, Florida
- +2 more
May 6, 2022
The HOPE Study: Characterizing Patients With Hepatitis B and C
Recruiting
- Hepatitis B, Chronic
- Hepatitis C
- Blood draws
- +4 more
-
Washington, District of Columbia
- +3 more
Jan 3, 2022
HIV, AIDS Trial in Baltimore (Tenofovir, Hydroxyurea)
Completed
- HIV Infections
- AIDS
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
May 6, 2021
Chronic Hepatitis B Trial in Baltimore, Auckland (Selgantolimod, Placebo, Hepatitis B virus (HBV) OAV Therapy)
HIV Trial in Baltimore (Enfuvirtide, Efavirenz, lamivudine, and tenofovir)
Completed
- HIV Infections
- Enfuvirtide
- Efavirenz, lamivudine, and tenofovir
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
May 6, 2021
Biobank, Treatment Response and Outcome Predictor
Recruiting
- Coronavirus Infections
- Observational Study
-
Milan, Lombardy, Italy
- +12 more
Dec 23, 2022
Covid-19 Prevention Trial in Belgium, United States (Ad26.COV2.S, Placebo)
Active, not recruiting
- Covid-19 Prevention
- Ad26.COV2.S
- Placebo
-
San Diego, California
- +11 more
Mar 15, 2022
COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,
Completed
- COVID-19
- +3 more
- Hydroxychloroquine Sulfate
- Ascorbic Acid
-
Los Angeles, California
- +7 more
Dec 14, 2021
Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)
Completed
- Chronic Hepatitis C
-
Baltimore, MarylandInstitute of Human Virology University of Maryland
Apr 26, 2021
Herpes Simplex Type 2 Trial in Portland, Houston, Seattle (HerpV and QS-21, Placebo)
Completed
- Herpes Simplex Type 2
- HerpV and QS-21
- Placebo
-
Portland, Oregon
- +4 more
Jun 22, 2021
Genital Herpes Trial in United States (mRNA-1608, BEXSERO)
Recruiting
- Genital Herpes
- mRNA-1608
- BEXSERO
-
Birmingham, Alabama
- +24 more
Sep 11, 2023
Influenza, Influenza Immunisation Trial in United States (AF03, Delta Inulin-CpG55.2, Influenza Virus Quadrivalent Inactivated
COHIVE: Coronavirus Outcomes in HIV Evaluation in Resource
Completed
- HIV-infection/Aids
- Coronavirus Infection
-
Buenos Aires, Ciudad De Buenos Aires, Argentina
- +14 more
Mar 16, 2022
During Enterovirus Meningitis in Paediatric Populations.
Not yet recruiting
- Meningitis Enterovirus
- Cytokine level in blood and CSF
-
Clermont-Ferrand, Aura, FranceUniversity Hospital, Clermont Ferrand
Jan 13, 2021